
Lipocine Inc.
LPCNHealthcare|Biotechnology|US
$1.57
+0.04 (+2.61%)
DCF Value
$0.67
Tangible Book / Share
$2.57
Cash / Share
$2.60
Next Earnings Report
Mar 8, 2027
EPS est. -$0.33 · Revenue est. $162.5K
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Feb 26, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (1)
Aug 2027
Est. completion
Recent Press Releases
Lipocine Announces Financial Results for the Third Quarter of 2026
Nov 5, 2026 · PRNewsWire
Lipocine Announces Health Canada Approval of TLANDO® for Testosterone Replacement Therapy
Oct 7, 2026 · PRNewsWire
Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression
Sep 14, 2026 · PRNewsWire
Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 10, 2026 · PRNewsWire
SEC Filings (81)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 5, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Oct 20, 2026 | 8-K | Material event | DocumentIndex |
| Oct 7, 2026 | 8-K | Material event | DocumentIndex |
| Sep 16, 2026 | 8-K | Material event | DocumentIndex |
| Sep 14, 2026 | 8-K | Material event | DocumentIndex |
| Sep 11, 2026 | 8-K | Material event | DocumentIndex |
| Sep 10, 2026 | 8-K | Material event | DocumentIndex |
| Aug 21, 2026 | 8-K/A | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 4, 2026 | 8-K | Material event | DocumentIndex |
| Aug 4, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 3, 2026 | 8-K | Material event | DocumentIndex |
| Jun 12, 2026 | 8-K | Material event | DocumentIndex |
| Jun 9, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jun 4, 2026 | 8-K | Material event | DocumentIndex |
| Jun 4, 2026 | 8-K | Material event | DocumentIndex |
| May 26, 2026 | 8-K | Material event | DocumentIndex |
| May 19, 2026 | 8-K | Material event | DocumentIndex |
| May 18, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| May 7, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Apr 21, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 21, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 21, 2026 | 8-K | Material event | DocumentIndex |
| Apr 2, 2026 | 8-K | Material event | DocumentIndex |
| Apr 2, 2026 | 8-K | Material event | DocumentIndex |
| Mar 10, 2026 | 8-K | Material event | DocumentIndex |
| Mar 10, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 4, 2026 | 8-K | Material event | DocumentIndex |
| Feb 26, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Feb 18, 2026 | 8-K | Material event | DocumentIndex |
| Feb 18, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 20, 2026 | 8-K | Material event | DocumentIndex |
| Jan 12, 2026 | 8-K | Material event | DocumentIndex |
| Jan 12, 2026 | 8-K | Material event | DocumentIndex |